Search

Your search keyword '"Verma, Ravinder"' showing total 317 results
Start Over Author "Verma, Ravinder"
317 results on '"Verma, Ravinder"'

3. Barriers to Smart Home Technologies in India

Author

Joy, Justin, Srinath, S., Verma, Ravinder Kumar, Shrivastava, Manish Kumar, Rannenberg, Kai, Editor-in-Chief, Soares Barbosa, Luís, Editorial Board Member, Carette, Jacques, Editorial Board Member, Tatnall, Arthur, Editorial Board Member, Neuhold, Erich J., Editorial Board Member, Stiller, Burkhard, Editorial Board Member, Stettner, Lukasz, Editorial Board Member, Pries-Heje, Jan, Editorial Board Member, Kreps, David, Editorial Board Member, Rettberg, Achim, Editorial Board Member, Furnell, Steven, Editorial Board Member, Mercier-Laurent, Eunika, Editorial Board Member, Winckler, Marco, Editorial Board Member, Malaka, Rainer, Editorial Board Member, Sharma, Sujeet K., editor, Dwivedi, Yogesh K., editor, Metri, Bhimaraya, editor, Lal, Banita, editor, and Elbanna, Amany, editor

Published
2024
Full Text
View/download PDF

4. Understanding the Usage and Opinion Formation on LinkedIn: Uses and Gratifications Theory

Author

Verma, Ravinder Kumar, Sengupta, Sujoy, Ilavarasan, P. Vigneswara, Kar, Arpan Kumar, Rannenberg, Kai, Editor-in-Chief, Soares Barbosa, Luís, Editorial Board Member, Carette, Jacques, Editorial Board Member, Tatnall, Arthur, Editorial Board Member, Neuhold, Erich J., Editorial Board Member, Stiller, Burkhard, Editorial Board Member, Stettner, Lukasz, Editorial Board Member, Pries-Heje, Jan, Editorial Board Member, Kreps, David, Editorial Board Member, Rettberg, Achim, Editorial Board Member, Furnell, Steven, Editorial Board Member, Mercier-Laurent, Eunika, Editorial Board Member, Winckler, Marco, Editorial Board Member, Malaka, Rainer, Editorial Board Member, Sharma, Sujeet K., editor, Dwivedi, Yogesh K., editor, Metri, Bhimaraya, editor, Lal, Banita, editor, and Elbanna, Amany, editor

Published
2024
Full Text
View/download PDF

5. Portfolio Selection Using Network Filtering Methods: A Graph Theoretic Approach

Author

Bhatacharjee, Biplab, Verma, Ravinder Kumar, Rannenberg, Kai, Editor-in-Chief, Soares Barbosa, Luís, Editorial Board Member, Carette, Jacques, Editorial Board Member, Tatnall, Arthur, Editorial Board Member, Neuhold, Erich J., Editorial Board Member, Stiller, Burkhard, Editorial Board Member, Stettner, Lukasz, Editorial Board Member, Pries-Heje, Jan, Editorial Board Member, Kreps, David, Editorial Board Member, Rettberg, Achim, Editorial Board Member, Furnell, Steven, Editorial Board Member, Mercier-Laurent, Eunika, Editorial Board Member, Winckler, Marco, Editorial Board Member, Malaka, Rainer, Editorial Board Member, Sharma, Sujeet K., editor, Dwivedi, Yogesh K., editor, Metri, Bhimaraya, editor, Lal, Banita, editor, and Elbanna, Amany, editor

Published
2024
Full Text
View/download PDF

20. Customers’ Willingness to Use New OTT Media Platforms in India

Author

Chakraborty, Imon, Verma, Ravinder Kumar, Joshi, Mohit Hiteshkumar, Ilavarasan, P. Vigneswara, Kacprzyk, Janusz, Series Editor, Gomide, Fernando, Advisory Editor, Kaynak, Okyay, Advisory Editor, Liu, Derong, Advisory Editor, Pedrycz, Witold, Advisory Editor, Polycarpou, Marios M., Advisory Editor, Rudas, Imre J., Advisory Editor, Wang, Jun, Advisory Editor, Tuba, Milan, editor, Akashe, Shyam, editor, and Joshi, Amit, editor

Published
2022
Full Text
View/download PDF

23. Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier.

Author

WADHWA, KARAN, CHAUHAN, PAYAL, KUMAR, SHOBHIT, PAHWA, RAKESH, VERMA, RAVINDER, GOYAL, RAJAT, SINGH, GOVIND, SHARMA, ARCHANA, RAO, NEHA, and KAUSHIK, DEEPAK

Subjects
BRAIN tumors, BLOOD-brain barrier, NANOCARRIERS, GLIOBLASTOMA multiforme, NANODIAMONDS
Abstract

Background: Glioblastoma multiforme (GBM) is recognized as the most lethal and most highly invasive tumor. The high likelihood of treatment failure arises fromthe presence of the blood-brain barrier (BBB) and stemcells around GBM, which avert the entry of chemotherapeutic drugs into the tumormass. Objective: Recently, several researchers have designed novel nanocarrier systems like liposomes, dendrimers, metallic nanoparticles, nanodiamonds, and nanorobot approaches, allowing drugs to infiltrate the BBB more efficiently, opening up innovative avenues to prevail over therapy problems and radiation therapy. Methods: Relevant literature for this manuscript has been collected from a comprehensive and systematic search of databases, for example, PubMed, Science Direct, Google Scholar, and others, using specific keyword combinations, including "glioblastoma," "brain tumor," "nanocarriers," and several others. Conclusion: This review also provides deep insights into recent advancements in nanocarrier-based formulations and technologies for GBM management. Elucidation of various scientific advances in conjunction with encouraging findings concerning the future perspectives and challenges of nanocarriers for effective brain tumor management has also been discussed. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

24. Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer’s Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside

Author

Walia, Vaibhav, Kaushik, Deepak, Mittal, Vineet, Kumar, Kuldeep, Verma, Ravinder, Parashar, Jatin, Akter, Rokeya, Rahman, Md. Habibur, Bhatia, Saurabh, Al-Harrasi, Ahmed, Karthika, Chenmala, Bhattacharya, Tanima, Chopra, Hitesh, and Ashraf, Ghulam Md

Published
2022
Full Text
View/download PDF

28. An Approach to End to End Anonymity

Author

Gupta, Ayush, Verma, Ravinder, Shishodia, Mrigendra, Chaurasiya, Vijay, Kacprzyk, Janusz, Series Editor, Gunjan, Vinit Kumar, editor, Zurada, Jacek M., editor, Raman, Balasubramanian, editor, and Gangadharan, G. R., editor

Published
2020
Full Text
View/download PDF

29. Inequalities in Ride-Hailing Platforms

Author

Verma, Ravinder Kumar, Ilavarasan, P. Vigneswara, Kar, Arpan Kumar, de Bruin, Marjan, Series Editor, Padovani, Claudia, Series Editor, Athique, Adrian, editor, and Parthasarathi, Vibodh, editor

Published
2020
Full Text
View/download PDF

30. Exploration of therapeutic applicability and different signaling mechanism of various phytopharmacological agents for treatment of breast cancer

Author

Singh, Vandana, Kumar, Kuldeep, Purohit, Deepika, Verma, Ravinder, Pandey, Parijat, Bhatia, Saurabh, Malik, Vinay, Mittal, Vineet, Rahman, Md. Habibur, Albadrani, Ghadeer M., Arafah, Mohammed W., El-Demerdash, Fatma M., Akhtar, Muhammad Furqan, Saleem, Ammara, Kamel, Mohamed, Najda, Agnieszka, Abdel-Daim, Mohamed M., and Kaushik, Deepak

Published
2021
Full Text
View/download PDF

32. Authenticating Fake News: An Empirical Study in India

Author

Prakash, Gautam, Verma, Ravinder Kumar, Ilavarasan, P. Vigneswara, Kar, Arpan K., Rannenberg, Kai, Editor-in-Chief, Sakarovitch, Jacques, Editorial Board Member, Goedicke, Michael, Editorial Board Member, Tatnall, Arthur, Editorial Board Member, Neuhold, Erich J., Editorial Board Member, Pras, Aiko, Editorial Board Member, Tröltzsch, Fredi, Editorial Board Member, Pries-Heje, Jan, Editorial Board Member, Kreps, David, Editorial Board Member, Reis, Ricardo, Editorial Board Member, Furnell, Steven, Editorial Board Member, Furbach, Ulrich, Editorial Board Member, Winckler, Marco, Editorial Board Member, Malaka, Rainer, Editorial Board Member, Dwivedi, Yogesh, editor, Ayaburi, Emmanuel, editor, Boateng, Richard, editor, and Effah, John, editor

Published
2019
Full Text
View/download PDF

46. Correction to: Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer’s Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside

Author

Walia, Vaibhav, Kaushik, Deepak, Mittal, Vineet, Kumar, Kuldeep, Verma, Ravinder, Parashar, Jatin, Akter, Rokeya, Rahman, Md. Habibur, Bhatia, Saurabh, Al-Harrasi, Ahmed, Karthika, Chenmala, Bhattacharya, Tanima, Chopra, Hitesh, and Ashraf, Ghulam Md

Published
2022
Full Text
View/download PDF

47. RETRACTED: QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics.

Author

Arora, Deepshi, Bhatt, Shailendra, Kumar, Manish, Verma, Ravinder, Taneja, Yugam, Kausha, Nikita, Tiwari, Abhishek, Tiwari, Varsha, Alexiou, Athanasios, Albogami, Sarah, Alotaibi, Saqer S., Mittal, Vineet, Singla, Rajeev K., Kaushik, Deepak, and Batiha, Gaber El-Saber

Abstract

Alzheimer's disease (AD) is a neurodegenerative disease that affects a wide range of populations and is the primary cause of death in various countries. The treatment of AD is still restricted to oral conventional medicines that act only superficially. Fabrication of intranasal solid lipid nanoparticulate system for the uptake of therapeutic agents will act as a convincing approach with limited off-site toxicity and increased pharmacological activity. The objective of this study was to formulate, optimize, and evaluate the efficiency of rivastigmine tartrate (RT)-loaded intranasal solid lipid nanoparticles (SLNs) employing the solvent-evaporation diffusion method. To optimize the formulation parameters, the central composite design (CCD) was used. Lipid concentration (X1) and surfactant concentration (X2) were considered to be independent variables, while particle size (Y1), percentage entrapment efficiency (Y2), and percentage drug release (Y3) were considered as responses. The solid lipid was glyceryl monostearate, while the surfactant was polysorbate 80. The optimized formulation has a particle size of 110.2 nm, % entrapment efficiency of 82.56%, and % drug release of 94.86%. The incompatibility of drug excipients was established by differential scanning calorimetry (DSC) and Fourier-transform infrared spectroscopy (FTIR). Nasal histopathology tests on sheep mucosa revealed that the developed SLNs were safe to utilize for intranasal delivery with no toxicity. Ex vivo permeation investigations revealed that the flux and diffusion coefficients for RT solid lipid nanoparticles and RT solution were 3.378 g/cm² /h and 0.310-3 cm² /h, respectively. Stability studies demonstrated that the developed SLNs were stable when stored under various storage conditions. The viability and vitality of adopting a lipid particle delivery system for improved bioavailability via the intranasal route were also established in the in vivo pharmacokinetic investigations. According to the histopathological and pharmacokinetic investigations, the developed formulations were safe, non-lethal, efficient, and robust. These results suggest the potentiality provided by rivastigmine tartrate-loaded solid lipid nanoparticles for nasal delivery. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results